X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3965) 3965
Publication (509) 509
Newsletter (119) 119
Magazine Article (33) 33
Newspaper Article (33) 33
Book Review (31) 31
Book Chapter (15) 15
Dissertation (14) 14
Government Document (4) 4
Conference Proceeding (2) 2
Journal / eJournal (2) 2
Paper (2) 2
Streaming Video (2) 2
Web Resource (2) 2
Reference (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
mefloquine (2454) 2454
humans (2451) 2451
malaria (1566) 1566
animals (1408) 1408
male (1187) 1187
antimalarials - therapeutic use (1126) 1126
female (1080) 1080
index medicus (1077) 1077
adult (977) 977
plasmodium falciparum - drug effects (940) 940
mefloquine - therapeutic use (828) 828
malaria, falciparum - drug therapy (825) 825
antimalarials - pharmacology (815) 815
drug resistance (805) 805
tropical medicine (764) 764
plasmodium falciparum (652) 652
chloroquine (591) 591
infectious diseases (568) 568
adolescent (559) 559
mefloquine - pharmacology (553) 553
parasitology (547) 547
pharmacology & pharmacy (534) 534
child (529) 529
middle aged (528) 528
parasitic diseases (523) 523
antimalarials - adverse effects (485) 485
malaria - drug therapy (483) 483
antimalarials - administration & dosage (475) 475
drug therapy, combination (474) 474
public, environmental & occupational health (464) 464
malaria - prevention & control (463) 463
mefloquine - adverse effects (457) 457
antimalarials (424) 424
research (411) 411
medicine, general & internal (402) 402
microbiology (393) 393
chloroquine - pharmacology (382) 382
drug combinations (381) 381
artesunate (379) 379
mefloquine - administration & dosage (371) 371
child, preschool (369) 369
travel (365) 365
plasmodium-falciparum (364) 364
thailand (358) 358
treatment outcome (338) 338
malaria, falciparum - parasitology (325) 325
plasmodium falciparum - genetics (325) 325
chloroquine - therapeutic use (318) 318
artemisinins - therapeutic use (310) 310
drug therapy (308) 308
artemisinin (296) 296
efficacy (295) 295
parasites (293) 293
plasmodium-falciparum malaria (290) 290
mice (281) 281
artemisinins (271) 271
drugs (267) 267
quinine (264) 264
infant (253) 253
children (248) 248
resistance (246) 246
malaria, falciparum - epidemiology (240) 240
in-vitro (239) 239
prophylaxis (235) 235
pregnancy (232) 232
health aspects (226) 226
sesquiterpenes - therapeutic use (225) 225
pharmacokinetics (210) 210
pyrimethamine - therapeutic use (209) 209
chloroquine resistance (205) 205
antimalarials - pharmacokinetics (201) 201
artemisinins - pharmacology (201) 201
quinolines - pharmacology (201) 201
artemether (200) 200
malaria, falciparum - prevention & control (196) 196
aged (195) 195
sulfadoxine - therapeutic use (194) 194
quinine - pharmacology (193) 193
artemether-lumefantrine (192) 192
combination (190) 190
analysis (187) 187
plasmodium falciparum - isolation & purification (185) 185
mefloquine resistance (184) 184
artemisinins - administration & dosage (182) 182
protozoan proteins - genetics (174) 174
arctic medicine. tropical medicine (173) 173
africa (171) 171
pyrimethamine (170) 170
immunology (169) 169
quinolines - therapeutic use (165) 165
infections (163) 163
young adult (162) 162
infectious and parasitic diseases (161) 161
dose-response relationship, drug (160) 160
sulfadoxine-pyrimethamine (160) 160
halofantrine (159) 159
travelers (159) 159
invitro (156) 156
prevention (155) 155
risk factors (155) 155
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3793) 3793
French (185) 185
German (67) 67
Spanish (26) 26
Portuguese (25) 25
Chinese (17) 17
Japanese (17) 17
Dutch (10) 10
Danish (7) 7
Italian (7) 7
Russian (5) 5
Hebrew (4) 4
Hungarian (4) 4
Norwegian (4) 4
Swedish (3) 3
Turkish (3) 3
Korean (2) 2
Czech (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


WHO Drug Information, ISSN 1010-9609, 04/2017, Volume 31, Issue 2, p. 172
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 09/2016, Volume 63, Issue 6, pp. 784 - 791
Journal Article
Free Radical Biology and Medicine, ISSN 0891-5849, 10/2015, Volume 87, pp. S70 - S71
Journal Article
In vitro activity of mefloquine and its enantiomers against Plasmodium falciparum, 12/2002
The in vitro activity of rac-mefloquine hydrochloride and its pure enantiomers was tested against a chloroquine-resistant (PF.IBS2) strain of Plasmodium... 
mefloquine, enantiomer, antiparasite, Plasmodium falciparum
Journal
Cancer, ISSN 0008-543X, 04/2019, Volume 125, Issue 8, pp. 1384 - 1385
Journal Article
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, ISSN 1469-493X, 2018, Volume 11, Issue 11, p. CD011444
Background The World Health Organization recommends intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine-pyrimethamine for malaria for all... 
Abortion, Spontaneous [chemically induced; epidemiology] | HIV Infections [complications] | ANTIMALARIAL AGENTS | Africa South of the Sahara [epidemiology] | EFFICACY | LOW-BIRTH-WEIGHT | Humans | Trimethoprim | SULFADOXINE-PYRIMETHAMINE RESISTANCE | Thailand [epidemiology] | PROPHYLAXIS | MEDICINE, GENERAL & INTERNAL | Insecticide-Treated Bednets | Parasitemia [epidemiology] | Combination | PLASMODIUM-FALCIPARUM | INFANTS | Female | INFECTION | Pregnancy Complications, Parasitic [epidemiology; prevention & control] | Infant, Low Birth Weight | Mefloquine [adverse effects; therapeutic use] | Drug Therapy | RISK | Antimalarials [adverse effects; therapeutic use] | Dizziness [chemically induced; epidemiology] | Randomized Controlled Trials as Topic | Sulfadoxine [adverse effects; therapeutic use] | Pregnancy | Malaria [epidemiology; prevention & control] | HIV | Vomiting [chemically induced; epidemiology] | Sulfamethoxazole Drug Combination [therapeutic use] | Drug Combinations | Pyrimethamine [adverse effects; therapeutic use] | Pyrimethamine - therapeutic use | Antimalarials - adverse effects | HIV Seronegativity | Placenta Diseases - epidemiology | Anemia - epidemiology | Pregnancy Complications, Infectious - epidemiology | Stillbirth | Antimalarials - therapeutic use | Parasitemia - drug therapy | Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use | Placenta Diseases - parasitology | Mefloquine - adverse effects | Malaria - prevention & control | Vomiting - chemically induced | Mefloquine - therapeutic use | Sulfadoxine - therapeutic use | Pregnancy Complications, Infectious - prevention & control | Pregnancy Complications - chemically induced | Drug Therapy, Combination
Journal Article
Tropical Medicine & International Health, ISSN 1360-2276, 12/2006, Volume 11, Issue 12, pp. 1800 - 1807
Summary Objective  To determine the efficacy of artemether–lumefantrine malaria treatment, as an alternative to artesunate + mefloquine, which is becoming... 
artéméther–luméfantrine | Cambodge | Cambodia | études cliniques | fallo terapéutico | malaria | artesunate + mefloquine | artesunato + mefloquina | paludisme | ensayos de eficacia | treatment failure | artemeter–lumefantrina | efficacy trials | artemether–lumefantrine | échec du traitement | artésunate + méfloquine | Artesunate + mefloquine | Treatment failure | Efficacy trials | Malaria | Artemether-lumefantrine | artesunate plus mefloquine | BENFLUMETOL | CHLOROQUINE | TROPICAL MEDICINE | WESTERN THAILAND | artemether-lumefantrine | IN-VITRO | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | PHARMACOKINETICS | PLASMODIUM-FALCIPARUM | ARTESUNATE-MEFLOQUINE | DOUBLE-BLIND | MEFLOQUINE RESISTANCE | QUININE | Parasitic Sensitivity Tests | Humans | Fluorenes - therapeutic use | Antimalarials - blood | Male | Plasmodium falciparum - drug effects | Sesquiterpenes - therapeutic use | Malaria, Falciparum - blood | Mefloquine - therapeutic use | Treatment Failure | Adult | Female | Fluorenes - blood | Drug Therapy, Combination | Child | Malaria, Falciparum - drug therapy | Acute Disease | Treatment Outcome | Antimalarials - therapeutic use | Ethanolamines - blood | Animals | Artemisinins - therapeutic use | Adolescent | Ethanolamines - therapeutic use | Dietary Supplements | Drug Combinations | Drug therapy | Comparative studies | Pharmacology | Epidemiology | Medical treatment | Tropical diseases
Journal Article
Stereospecific Determination of Mefloquine in Whole Blood by HPLC, 12/2003
Mefloquine, as a racemic mixture, is used for the treatment and prophylaxis of malaria. Stereoselective pharmacodynamic and pharmacokinetic differences has... 
Mefloquine, Enantiomer, Derivatization, Whole blood, RP-HPLC
Journal
Journal of Colloid And Interface Science, ISSN 0021-9797, 10/2014, Volume 431, pp. 24 - 30
The antiparasitic properties of antiparasitic drugs are believed to be associated with their interactions with the protozoan membrane, encouraging research on... 
Mefloquine hydrochloride | DPPG | Malaria | Langmuir monolayers | PM-IRRAS | DODAB | Stearic acid | Antiparasitic drug | DPPC | ANTIMALARIAL-DRUG MEFLOQUINE | CHEMISTRY, PHYSICAL | LANGMUIR | PHASE | FILMS | COLLAPSE | Cell Membrane - chemistry | Mefloquine - chemistry | Membranes, Artificial | Unilamellar Liposomes - chemistry | Antimalarials - chemistry | Mefloquine | Monomolecular films
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2009, Volume 361, Issue 5, pp. 455 - 467
Journal Article
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 12/2006, Volume 50, Issue 12, pp. 4132 - 4143
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 02/2017, Volume 796, p. 215
Mefloquine constitutes a multitarget antimalaric that inhibits cation currents. However, the effect and the binding site of this compound on Na.sup.+ channels... 
Molecular dynamics | Mefloquine
Journal Article
The Lancet, ISSN 0140-6736, 2004, Volume 364, Issue 9432, pp. 438 - 447
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 02/2018, Volume 2018, Issue 2, p. CD008152
Background The 8-aminoquinoline (8AQ) drugs act on Plasmodium falciparum gametocytes, which transmit malaria from infected people to mosquitoes. In 2012, the... 
45 MG PRIMAQUINE | ARTEMETHER-LUMEFANTRINE | SULFADOXINE-PYRIMETHAMINE | Artemisinins [administration & dosage; therapeutic use] | Quinine [therapeutic use] | Plasmodium falciparum [drug effects] | Malaria, Falciparum [parasitology; prevention & control; transmission] | LOW-DOSE PRIMAQUINE | GAMETOCYTOCIDAL ACTIVITY | Primaquine [administration & dosage] | Glucosephosphate Dehydrogenase Deficiency [diagnosis] | SPORONTOCIDAL TREATMENT | Randomized Controlled Trials as Topic | MEDICINE, GENERAL & INTERNAL | Sulfadoxine [administration & dosage] | MALARIA CONTROL | DIHYDROARTEMISININ-PIPERAQUINE | THERAPEUTIC-EFFICACY | Pyrimethamine [administration & dosage] | ARTESUNATE-MEFLOQUINE | Antimalarials [administration & dosage] | Mefloquine [therapeutic use] | Drug Combinations | Chloroquine [therapeutic use] | Malaria, Falciparum - prevention & control | Humans | Artemisinins - administration & dosage | Sulfadoxine - administration & dosage | Chloroquine - therapeutic use | Plasmodium falciparum - drug effects | Primaquine - administration & dosage | Glucosephosphate Dehydrogenase Deficiency - diagnosis | Malaria, Falciparum - parasitology | Malaria, Falciparum - transmission | Quinine - therapeutic use | Primaquine - analogs & derivatives | Artemisinins - therapeutic use | Mefloquine - therapeutic use | Antimalarials - administration & dosage | Pyrimethamine - administration & dosage | Time Factors | Mefloquine - administration & dosage | Non-Randomized Controlled Trials as Topic | Adult | Chloroquine - administration & dosage | Child
Journal Article